BRIEF-Kalytera submits phase 2 study protocol to IRBS for cannabidiol
August 14, 2017 at 08:35 AM EDT
* Kalytera submits phase 2 study protocol to IRBS for cannabidiol in the prevention of graft versus host disease
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|